Cargando…

Glucose variability for cardiovascular risk factors in type 2 diabetes: a meta-analysis

AIMS: It is consensus that glucose variability (GV) plays an important role in maccomplications of type 2 diabetes, but whether GV has a causal role is not yet clear for cardiovascular disease (CVD). This study sought to explore the effect on GV for CVD risk factors with type 2 diabetes. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Shuang, Yin, Hang, Wei, Chunxiang, Xie, Linjun, He, Hua, Liu, Xiaoquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686902/ https://www.ncbi.nlm.nih.gov/pubmed/29164077 http://dx.doi.org/10.1186/s40200-017-0323-5

Ejemplares similares

Cardiovascular Autonomic Neuropathy and Glucose Variability in Patients With Type 1 Diabetes: Is There an Association?
por: Nyiraty, Szabolcs, et al.
Publicado: (2018)

Glucose variability: a new risk factor for cardiovascular disease
por: Belli, Martina, et al.
Publicado: (2023)

Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
por: Patti, Angelo Maria, et al.
Publicado: (2020)

Glucose lowering does not necessarily reduce cardiovascular risk in type 2 diabetes
por: Bourazana, Angeliki, et al.
Publicado: (2022)

Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Patients With Type 2 Diabetes and Other Risk Factors for Cardiovascular Disease: A Meta-analysis
por: Bhattarai, Mukul, et al.
Publicado: (2022)

Continuous glucose monitoring to assess glucose variability in type 3c diabetes
por: Lee, Victoria T. Y., et al.
Publicado: (2022)

Effect of Glucose Variability on the Long-Term Risk of Microvascular Complications in Type 1 Diabetes
por: Kilpatrick, Eric S., et al.
Publicado: (2009)

Impact of Real-Time Continuous Glucose Monitoring Use on Glucose Variability and Endothelial Function in Adolescents with Type 1 Diabetes: New Technology—New Possibility to Decrease Cardiovascular Risk?
por: Jamiołkowska, Milena, et al.
Publicado: (2016)

Tackling Cardiovascular Risk in Type 2 Diabetes: Does Baseline Glucose Control Matter?
por: Nicholls, Stephen J., et al.
Publicado: (2018)

Evaluating Alzheimer's Disease Progression by Modeling Crosstalk Network Disruption
por: Liu, Haochen, et al.
Publicado: (2016)

Effects of Exercise on Cardiovascular Risk Factors in Type 2 Diabetes: A meta-analysis
por: Chudyk, Anna, et al.
Publicado: (2011)

Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes
por: Lu, Jingyi, et al.
Publicado: (2018)

Impact of Fat Intake on Blood Glucose Control and Cardiovascular Risk Factors in Children and Adolescents with Type 1 Diabetes
por: Garonzi, Chiara, et al.
Publicado: (2021)

Role of glucose variability on linear growth in children with type 1 diabetes
por: Blasetti, Annalisa, et al.
Publicado: (2023)

Glycemic variability and cardiovascular disease in patients with type 2 diabetes
por: Martinez, Marcela, et al.
Publicado: (2021)

Variability in Annual Fasting Glucose and the Risk of Peripheral Artery Disease in Patients with Diabetes Mellitus
por: Chang, Yu-Shan, et al.
Publicado: (2021)

Factors Associated with Glycemic Variability in Patients with Type 2 Diabetes: Focus on Oral Hypoglycemic Agents and Cardiovascular Risk Factors
por: Yoo, Soyeon, et al.
Publicado: (2015)

Association of sleep quality with glycemic variability assessed by flash glucose monitoring in patients with type 2 diabetes
por: Yang, Yang, et al.
Publicado: (2021)

Impact of Visit-to-Visit Triglyceride-Glucose Index Variability on the Risk of Cardiovascular Disease in the Elderly
por: Chen, Fei, et al.
Publicado: (2022)

Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis
por: Li, Chun-xing, et al.
Publicado: (2021)

Relationship between acute glucose variability and cognitive decline in type 2 diabetes: A systematic review and meta-analysis
por: Chi, Haiyan, et al.
Publicado: (2023)

Variable content and distribution of arabinogalactan proteins in banana (Musa spp.) under low temperature stress
por: Yan, Yonglian, et al.
Publicado: (2015)

Genetic variability in sodium-glucose cotransporter 2 influences glycemic control and risk for diabetic retinopathy in type 2 diabetes patients
por: Klen, Jasna, et al.
Publicado: (2020)

Relationship of Hyperglycaemia, Hypoglycaemia, and Glucose Variability to Atherosclerotic Disease in Type 2 Diabetes
por: Magri, Caroline Jane, et al.
Publicado: (2018)

Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register
por: Ceriello, Antonio, et al.
Publicado: (2021)

Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2021)

Glycemic Control, Preexisting Cardiovascular Disease, and Risk of Major Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: Systematic Review With Meta‐Analysis of Cardiovascular Outcome Trials and Intensive Glucose Control Trials
por: Giugliano, Dario, et al.
Publicado: (2019)

Risk Factors for Cardiovascular Disease in Type 1 Diabetes
Publicado: (2016)

Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis
por: Deshpande, Radhika, et al.
Publicado: (2023)

Utility of Childhood Glucose Homeostasis Variables in Predicting Adult Diabetes and Related Cardiometabolic Risk Factors: The Bogalusa Heart Study
por: Nguyen, Quoc Manh, et al.
Publicado: (2010)

Sodium–glucose cotransporter 2 inhibitors reduce day‐to‐day glucose variability in patients with type 1 diabetes
por: Chiba, Koki, et al.
Publicado: (2020)

Cardiovascular Risk Factors: It's Time to Focus on Variability!
por: Barnett, Mallory P., et al.
Publicado: (2020)

Cardiovascular benefits and safety of sotagliflozin in type 2 diabetes mellitus patients with heart failure or cardiovascular risk factors: a bayesian network meta-analysis
por: Li, Jiyifan, et al.
Publicado: (2023)

The Correlation between Type 2 Diabetes Mellitus and Cardiovascular Disease Risk Factors in the Elderly
por: Zhang, Lijuan, et al.
Publicado: (2022)

Glucose Variability is Independently Correlated with Serum Level of Pigment Epithelium-Derived Factor in Type 2 Diabetes
por: Fujikawa, Tomoki, et al.
Publicado: (2021)

Serum Cytokines and Growth Factors in Subjects with Type 1 Diabetes: Associations with Time in Ranges and Glucose Variability
por: Klimontov, Vadim V., et al.
Publicado: (2023)

Association Between Hemoglobin Glycation Index and Risk of Cardiovascular Disease and All Cause Mortality in Type 2 Diabetic Patients: A Meta-Analysis
por: Wu, Jian-di, et al.
Publicado: (2021)

Effects of sodium–glucose cotransporter 2 inhibitors in addition to insulin therapy on cardiovascular risk factors in type 2 diabetes patients: A meta‐analysis of randomized controlled trials
por: Wu, Bingshu, et al.
Publicado: (2018)

Effects of Glucose Control and Variability on Endothelial Function and Repair in Adolescents with Type 1 Diabetes
por: Hoffman, Robert P., et al.
Publicado: (2013)

Fasting Blood Glucose-A Missing Variable for GFR-Estimation in Type 1 Diabetes?
por: Bjornstad, Petter, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o16uje4j850r0juvdrrsh6s7m9